United States Healthcare Equipment & Supplies

Beta Bionics Inc (BBNX)

Track

Over the past 90 days, Beta Bionics Inc. insiders have engaged in 27 transactions, resulting in a net sell value of approximately $472,476. All activity consisted of sales by executives, including the CFO and CEO. These transactions occurred following a 47.4% stock price increase and a positive earnings report in July 2026.
Ticker: BBNX Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Beta Bionics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Planned sale 29 Jun 2026
Value US$3,601,764.93 | Price 30.14 | Shares 37,481 (-34.3%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-30 2026-06-29 PlS Planned sale
2.6
Feider Stephen

Chief Financial Officer

Officer
37,481 -34.3%
30.14
US$3,601,765 		37,481 -34.3% 30.14 US$3,601,765
2026-06-29 2026-06-29 PrS Proposed sale
2.6
Stephen Feider

Officer

Officer
45,149
174.44
US$929,393 		45,149 174.44 US$929,393
2026-06-30 2026-06-26 PlS Planned sale
2.6
Feider Stephen

Chief Financial Officer

Officer
20,853 +47.7%
90.85
US$4,866,928 		20,853 +47.7% 90.85 US$4,866,928
2026-06-26 2026-06-26 PrS Proposed sale
2.6
Stephen Feider

Officer

Officer
5,104
17.05
US$87,007 		5,104 17.05 US$87,007
2026-06-25 2026-06-24 PlS Planned sale
2.6
Hopman Mark

Chief Commercial Officer

Officer
1,258 -1.0%
15.01
US$18,880 		1,258 -1.0% 15.01 US$18,880
2026-06-25 2026-06-24 PlS Planned sale
Jones Christy
Non-Executive Director
1,406 -5.1%
15.00
US$21,090 		1,406 -5.1% 15.00 US$21,090
2026-06-24 2026-06-24 PrS Proposed sale
2.6
Mark Hopman

Officer

Officer
1,258
14.97
US$18,827 		1,258 14.97 US$18,827
2026-06-24 2026-06-24 PrS Proposed sale
CHRISTINA JONES

Director

Non-Executive Director
1,406
13.67
US$19,220 		1,406 13.67 US$19,220
2026-06-05 2026-06-04 PlS Planned sale
Jones Christy
Non-Executive Director
2,811 -9.3%
14.00
US$39,354 		2,811 -9.3% 14.00 US$39,354
2026-06-05 2026-06-04 PlS Planned sale
2.6
Hopman Mark

Chief Commercial Officer

Officer
275 -0.2%
12.31
US$3,385 		275 -0.2% 12.31 US$3,385
2026-06-04 2026-06-04 PrS Proposed sale
CHRISTINA JONES

Director

Non-Executive Director
2,811
12.45
US$34,997 		2,811 12.45 US$34,997
2026-06-04 2026-06-04 PrS Proposed sale
2.6
Mark Hopman

Officer

Officer
275
12.31
US$3,385 		275 12.31 US$3,385
2026-06-03 2026-06-02 S Sale
2.6
Mensinger Mike

Chief Product Officer

Officer
4,378 -2.3%
12.61
US$55,194 		4,378 -2.3% 12.61 US$55,194
2026-06-03 2026-06-02 S Sale
2.6
Russell Steven Jon

Chief Medical Officer

Officer
4,222 -2.4%
12.61
US$53,227 		4,222 -2.4% 12.61 US$53,227
2026-06-03 2026-06-02 S Sale
2.6
Saint Sean

President & CEO

Executive Director
16,872 -3.9%
12.61
US$212,707 		16,872 -3.9% 12.61 US$212,707
2026-06-03 2026-06-02 S Sale
2.6
Feider Stephen

Chief Financial Officer

Officer
6,676 -3.9%
12.61
US$84,165 		6,676 -3.9% 12.61 US$84,165
2026-06-03 2026-06-02 S Sale
2.6
Hopman Mark

Chief Commercial Officer

Officer
5,329 -3.9%
12.61
US$67,183 		5,329 -3.9% 12.61 US$67,183
2026-06-03 2026-06-02 PrS Proposed sale
2.6
Michael R. Mensinger

Officer

Officer
4,378
12.79
US$55,995 		4,378 12.79 US$55,995
2026-06-03 2026-06-02 PrS Proposed sale
2.6
Steven Jon Russell

Officer

Officer
4,222
12.79
US$53,999 		4,222 12.79 US$53,999
2026-06-03 2026-06-02 PrS Proposed sale
2.6
Mark Hopman

Officer

Officer
5,329
12.79
US$68,158 		5,329 12.79 US$68,158
2026-06-03 2026-06-02 PrS Proposed sale
2.6
Stephen Feider

Officer

Officer
6,676
12.79
US$85,386 		6,676 12.79 US$85,386
2026-06-03 2026-06-02 PrS Proposed sale
2.6
Sean Saint

Officer; Director

Executive Director
16,872
12.79
US$215,793 		16,872 12.79 US$215,793
2026-05-26 2026-05-22 PlS Planned sale
Lezack Adam
Non-Executive Director
998 -3.5%
11.21
US$11,188 		998 -3.5% 11.21 US$11,188
2026-05-26 2026-05-21 PlS Planned sale
Jones Christy
Non-Executive Director
1,998 -13.1%
9.95
US$19,880 		1,998 -13.1% 9.95 US$19,880
2026-05-26 2026-05-21 PlS Planned sale
Lezack Adam
Non-Executive Director
1,000 -8.0%
9.95
US$9,950 		1,000 -8.0% 9.95 US$9,950
2026-05-21 2026-05-21 PrS Proposed sale
CHRISTINA JONES

Director

Non-Executive Director
1,998
10.11
US$20,200 		1,998 10.11 US$20,200
2026-05-21 2026-05-21 PrS Proposed sale
ADAM LEZACK

Director

Non-Executive Director
1,998
10.11
US$20,200 		1,998 10.11 US$20,200
2026-03-05 2026-03-04 PlS Planned sale
2.6
Hopman Mark

Chief Commercial Officer

Officer
353 -0.3%
11.57
US$4,084 		353 -0.3% 11.57 US$4,084
2026-03-04 2026-03-04 PrS Proposed sale
2.6
Mark Hopman

Officer

Officer
353
11.57
US$4,084 		353 11.57 US$4,084
2026-03-04 2026-03-02 PrS Proposed sale
2.6
Michael R. Mensinger

Officer

Officer
1,064
12.52
US$13,321 		1,064 12.52 US$13,321
2026-03-04 2026-03-02 PrS Proposed sale
2.6
Stephen Feider

Officer

Officer
1,428
12.52
US$17,879 		1,428 12.52 US$17,879
2026-03-04 2026-03-02 PrS Proposed sale
2.6
Sean Saint

Officer; Director

Executive Director
3,384
12.52
US$42,368 		3,384 12.52 US$42,368
2026-03-03 2026-03-02 S Sale
2.6
Saint Sean

President & CEO

Executive Director
3,384 -0.8%
12.36
US$41,832 		3,384 -0.8% 12.36 US$41,832
2026-03-03 2026-03-02 S Sale
2.6
Feider Stephen

Chief Financial Officer

Officer
1,428 -0.8%
12.36
US$17,652 		1,428 -0.8% 12.36 US$17,652
2026-03-03 2026-03-02 S Sale
2.6
Mensinger Mike

Chief Product Officer

Officer
1,064 -0.6%
12.36
US$13,153 		1,064 -0.6% 12.36 US$13,153
2026-03-03 2026-03-02 S Sale
2.6
Hopman Mark

Chief Commercial Officer

Officer
834 -0.6%
12.36
US$10,310 		834 -0.6% 12.36 US$10,310
2026-03-03 2026-03-02 S Sale
2.6
Russell Steven Jon

Chief Medical Officer

Officer
1,026 -0.6%
12.36
US$12,683 		1,026 -0.6% 12.36 US$12,683
2026-01-07 2026-01-06 PlS Planned sale
2.6
Mensinger Mike

Chief Product Officer

Officer
2,200 -2.7%
30.10
US$66,221 		2,200 -2.7% 30.10 US$66,221
2026-01-05 2026-01-02 PlS Planned sale
2.6
Mensinger Mike

Chief Product Officer

Officer
600 -0.7%
30.20
US$18,118 		600 -0.7% 30.20 US$18,118
2026-01-05 2026-01-02 PlS Planned sale
2.6
Mensinger Mike

Chief Product Officer

Officer
7,200 -7.9%
29.56
US$212,832 		7,200 -7.9% 29.56 US$212,832
2026-01-05 2026-01-02 PlS Planned sale
2.6
Feider Stephen

Chief Financial Officer

Officer
20,000 -31.9%
29.53
US$590,680 		20,000 -31.9% 29.53 US$590,680
2026-01-02 2026-01-02 PrS Proposed sale
2.6
MICHAEL MENSINGER

Officer

Officer
10,000
30.47
US$304,700 		10,000 30.47 US$304,700
2026-01-02 2026-01-02 PrS Proposed sale
2.6
Stephen Feider

Officer

Officer
20,000
29.53
US$590,680 		20,000 29.53 US$590,680
2026-01-02 2026-01-02 PrS Proposed sale
2.6
Stephen Feider

Officer

Officer
20,000
29.53
US$590,680 		20,000 29.53 US$590,680
2026-03-16 2025-12-04 PlS Planned sale
2.6
Hopman Mark

Chief Commercial Officer

Officer
2,061 -1.5%
30.66
US$63,192 		2,061 -1.5% 30.66 US$63,192
2025-12-04 2025-12-04 PrS Proposed sale
2.6
Mark Hopman

Officer

Officer
2,061
30.66
US$63,192 		2,061 30.66 US$63,192
2026-03-16 2025-12-02 S Sale
2.6
Hopman Mark

Chief Commercial Officer

Officer
856 -0.6%
29.34
US$25,112 		856 -0.6% 29.34 US$25,112
2026-03-16 2025-12-02 S Sale
2.6
Russell Steven Jon

Chief Medical Officer

Officer
1,025 -0.6%
29.34
US$30,069 		1,025 -0.6% 29.34 US$30,069
2025-12-04 2025-12-02 PrS Proposed sale
2.6
Sean Saint

Officer; Director

Executive Director
3,278
29.34
US$96,163 		3,278 29.34 US$96,163
2025-12-04 2025-12-02 PrS Proposed sale
2.6
Stephen Feider

Officer

Officer
1,427
29.34
US$41,862 		1,427 29.34 US$41,862
2025-12-04 2025-12-02 PrS Proposed sale
2.6
Michael R. Mensinger

Officer

Officer
1,063
29.34
US$31,184 		1,063 29.34 US$31,184
2025-12-04 2025-12-02 S Sale
2.6
Saint Sean

President & CEO

Executive Director
3,278 -3.2%
29.34
US$96,163 		3,278 -3.2% 29.34 US$96,163
2025-12-04 2025-12-02 S Sale
2.6
Feider Stephen

Chief Financial Officer

Officer
1,427 -3.2%
29.34
US$41,862 		1,427 -3.2% 29.34 US$41,862
2025-12-04 2025-12-02 S Sale
2.6
Mensinger Mike

Chief Product Officer

Officer
1,063 -1.2%
29.34
US$31,184 		1,063 -1.2% 29.34 US$31,184
2025-12-02 2025-12-01 PlS Planned sale
Palasis Maria
Non-Executive Director
500 -5.6%
29.96
US$14,982 		500 -5.6% 29.96 US$14,982
2025-12-02 2025-12-01 PlS Planned sale
Palasis Maria
Non-Executive Director
906 -9.2%
29.33
US$26,570 		906 -9.2% 29.33 US$26,570
2025-12-02 2025-12-01 PlS Planned sale
Lezack Adam
Non-Executive Director
500 -5.6%
29.91
US$14,955 		500 -5.6% 29.91 US$14,955
2025-12-02 2025-12-01 PlS Planned sale
Lezack Adam
Non-Executive Director
906 -9.2%
29.35
US$26,588 		906 -9.2% 29.35 US$26,588
2025-11-05 2025-10-31 PlS Planned sale
Lezack Adam
Non-Executive Director
38 -0.4%
27.70
US$1,053 		38 -0.4% 27.70 US$1,053
2025-11-05 2025-10-31 PlS Planned sale
Lezack Adam
Non-Executive Director
1,368 -12.2%
26.85
US$36,727 		1,368 -12.2% 26.85 US$36,727
2025-11-05 2025-10-31 PlS Planned sale
Palasis Maria
Non-Executive Director
119 -1.2%
27.45
US$3,267 		119 -1.2% 27.45 US$3,267
2025-11-05 2025-10-31 PlS Planned sale
Palasis Maria
Non-Executive Director
1,287 -11.4%
26.86
US$34,567 		1,287 -11.4% 26.86 US$34,567
2025-10-31 2025-10-31 PrS Proposed sale
ADAM LEZACK

Director

Non-Executive Director
2,812
26.78
US$75,305 		2,812 26.78 US$75,305
2025-10-31 2025-10-31 PrS Proposed sale
MARIA PALASIS

Director

Non-Executive Director
2,812
26.78
US$75,305 		2,812 26.78 US$75,305
2025-10-07 2025-10-03 PlS Planned sale
2.6
Feider Stephen

Chief Financial Officer

Officer
1,154 -2.6%
22.28
US$25,709 		1,154 -2.6% 22.28 US$25,709
2025-10-07 2025-10-03 PlS Planned sale
2.6
Feider Stephen

Chief Financial Officer

Officer
3,828 -7.8%
21.52
US$82,368 		3,828 -7.8% 21.52 US$82,368
2025-10-03 2025-10-03 PrS Proposed sale
2.6
Stephen Feider

Officer

Officer
4,982
21.69
US$108,076 		4,982 21.69 US$108,076
2025-10-03 2025-10-01 PlS Planned sale
2.6
Feider Stephen

Chief Financial Officer

Officer
100 -0.2%
21.08
US$2,108 		100 -0.2% 21.08 US$2,108
2025-10-03 2025-10-01 PlS Planned sale
2.6
Feider Stephen

Chief Financial Officer

Officer
14,918 -25.3%
20.76
US$309,698 		14,918 -25.3% 20.76 US$309,698
2025-10-01 2025-10-01 PrS Proposed sale
2.6
Stephen Feider

Officer

Officer
15,018
20.76
US$311,837 		15,018 20.76 US$311,837
2025-09-09 2025-09-08 PlS Planned sale
2.6
Feider Stephen

Chief Financial Officer

Officer
9,900 -18.4%
21.13
US$209,151 		9,900 -18.4% 21.13 US$209,151
2025-09-08 2025-09-08 PrS Proposed sale
2.6
Feider Stephen

Officer

Officer
9,900
21.13
US$209,152 		9,900 21.13 US$209,152
2025-09-08 2025-09-05 PlS Planned sale
2.6
Hopman Mark

Chief Commercial Officer

Officer
11,411 -26.8%
20.56
US$234,657 		11,411 -26.8% 20.56 US$234,657
2025-09-08 2025-09-05 PlS Planned sale
2.6
Feider Stephen

Chief Financial Officer

Officer
100 -0.2%
21.00
US$2,100 		100 -0.2% 21.00 US$2,100
2025-09-05 2025-09-05 PrS Proposed sale
2.6
Hopman Mark

Officer

Officer
11,411
20.56
US$234,657 		11,411 20.56 US$234,657
Explore more

More insider trading research around Beta Bionics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America